Medical Condition News

RSS

Acetyl-L-carnitine likely to improve outcomes and recovery for individuals with SCI

A commonly used supplement is likely to improve outcomes and recovery for individuals who sustain a spinal cord injury (SCI), according to research conducted by University of Kentucky neuroscientists.

29 Sep 2011

Study links pain severity with depression

A new study in The Journal of Pain, published by the American Pain Society, www.ampainsoc.org, shows that changes in pain severity can predict subsequent depression severity and, likewise, a worsening change in depression is an equally strong predictor of subsequent pain severity.

29 Sep 2011

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

29 Sep 2011

DaTscan aids doctors in diagnosing patients with Parkinson's disease

Fifty thousand to 60,000 new cases of Parkinson's disease are diagnosed in the United States each year. Central DuPage Hospital (CDH) in Winfield, Ill., is among the first medical centers in North America to be using a new technology called DaTscan, an imaging tool that aids doctors in diagnosing patients who demonstrate Parkinsonian symptoms, like Parkinson's disease.

29 Sep 2011

Scientists discover effective target to kill late-stage metastatic prostate cancer cells

Purdue University scientists believe they have found an effective target for killing late-stage, metastatic prostate cancer cells.

29 Sep 2011

Intensive therapy at early ages improves social-communication skills in children with ASD

A primary characteristic of autism spectrum disorders (ASD) is impairments in social-communication skills. Children and adolescents with social-communication problems face difficulty understanding, interacting and relating with others. University of Missouri researchers found that children who receive more intensive therapy to combat these impairments, especially at early ages, achieve the best outcomes.

29 Sep 2011

Enrollment complete in Rexahn's Archexin Phase II trial for metastatic pancreatic cancer

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it has completed enrollment for its Phase II clinical trial of Archexin in metastatic pancreatic cancer.

29 Sep 2011

SanBio initiates SB623 Phase 1/2a clinical trial in ischemic stroke

SanBio, Inc. has announced that a patient at Stanford University Medical Center has become the first to be treated with SB623, a novel cell therapy for patients with disability resulting from ischemic stroke.

29 Sep 2011

Valeant's colesevelam New Drug Submission for hypercholesterolemia receives Canadian approval

Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant International (Barbados) SRL, has received notice that the New Drug Submission for colesevelam hydrochloride (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, has been approved by the Canadian regulatory authority Health Canada.

28 Sep 2011

XECAN's RFID Oncology Solution integrated with ThingMagic Astra UHF Reader

Trimble announced today that m, a leading provider of RFID patient safety solutions, has integrated the ThingMagic Astra UHF Reader into its RFID Oncology Solution. The XECAN solution enhances the patient experience and significantly assists in the goal of eliminating treatment errors allowing healthcare organizations to offer a safer and more inviting medical experience.

28 Sep 2011

Congress must not make cuts to crucial government-funded aging research

America's experts on aging are headed for meetings with their senators and representatives to underscore the needs of the country's senior population, spurred by the first-ever Take Action Week organized by The Gerontological Society of America - the nation's largest interdisciplinary organization devoted to the field of aging.

28 Sep 2011

Adamas begins ADS-5102 Phase 2/3 clinical trial in Parkinson's disease

Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has initiated a Phase 2/3 clinical trial of its proprietary investigational drug ADS-5102 (amantadine HCl extended release) for the treatment of levodopa induced dyskinesia (LID) in patients with Parkinson's disease.

28 Sep 2011

Yale researchers use AB SCIEX's QTRAP technology to synthesize phosphoproteins

AB SCIEX, a global leader in life science analytical technologies, today announced that Yale University researchers used QTRAP technology to prove the validity of a new approach to synthesize phosphoproteins.

28 Sep 2011

HealthyWomen launches web-based initiative to manage RA

Managing RA: The Strong Woman's Approach, is an online resource designed to educate and empower women living with rheumatoid arthritis (RA), launched today at HealthyWomen.org.

28 Sep 2011

YM BioSciences begins enrollment in CYT387 Phase II trial for myelofibrosis

YM BioSciences Inc. today announced that it has enrolled the first patients in its multi-center Phase II trial of CYT387 administered twice-daily (BID) for the treatment of myelofibrosis.

28 Sep 2011

Study examines psychosocial impact of cleft lip, palate on individuals in non-Anglo societies

One person's flaw may be another person's strength, according to a study of cultural perceptions of cleft lip and cleft palate. In the Western world, many people with these facial anomalies experience social and emotional difficulties because of the importance placed on appearance. In other parts of the world, a range of views are influenced by religion, superstition, and cultural prejudices.

28 Sep 2011

Long-term morbidity and mortality of NAFLD patients with advanced fibrosis, cirrhosis

Patients with non-alcoholic fatty liver disease (NAFLD) with advanced fibrosis or cirrhosis have a lower incidence of liver-related complications and hepatocellular carcinoma (HCC) than patients infected with hepatitis C virus (HCV), according to the prospective study published in the October issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.

28 Sep 2011

NIH-funded project to study risk factors for alcoholism in Native Americans

Scripps Research Institute Professor Cindy Ehlers has been awarded a prestigious $3.6 million MERIT Award grant by the National Institutes of Health (NIH) to study the risk factors for alcoholism in Native Americans.

28 Sep 2011

Survey: 59% of Americans say they are not concerned about sodium intake

Few Americans can tell you how much sodium they should consume each day and most aren't concerned with their personal sodium intake. According to the 2011 International Food Information Council Sodium Survey, 59 percent of Americans say they're not concerned about their sodium intake, consistent with findings in 2009.

28 Sep 2011

Lucky Strike to begin partnership with Breastcancer.org

Lucky Strike, the nation's premiere chain of upscale bowling and lounges, will begin its partnership with Breastcancer.org this month. Breastcancer.org is the leading online resource for breast health and breast cancer information and support.

28 Sep 2011